Search

Now showing items 1-10 of 44

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma

Haider, S; Wang, J; Nagano, A; Desai, A; Arumugam, P; Dumartin, L; Fitzgibbon, J; Hagemann, T; Marshall, JF; Kocher, HM;... (2014)

Improved usage of the repertoires of pancreatic ductal adenocarcinoma (PDAC) profiles is crucially needed to guide the development of predictive and prognostic tools that could inform the selection of treatment options.

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma.

Haider, S; Wang, J; Nagano, A; Desai, A; Arumugam, P; Dumartin, L; Fitzgibbon, J; Hagemann, T; Marshall, JF; Kocher, HM;... (2014)

MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma

Bladen, JC; Wang, J; Sangaralingam, A; Moosajee, M; Fitchett, C; Chelala, C; Beaconsfield, M; O'Toole, EA; Philpott, MP; Ezra, DG (2018-05-14)

CSF1R(+) Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype

Candido, JB; Morton, JP; Bailey, P; Campbell, AD; Karim, SA; Jamieson, T; Lapienyte, L; Gopinathan, A; Clark, W; McGhee, EJ;... (2018-05-01)

Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma

Dawkins, JBN; Wang, J; Maniati, E; Heward, JA; Koniali, L; Kocher, HM; Martin, SA; Chelala, C; Balkwill, FR; Fitzgibbon, J;... (2016-08-15)

Lamin B1 regulates somatic mutations and progression of B-cell malignancies

Klymenko, T; Bloehdorn, J; Bahlo, J; Robrecht, S; Akylzhanova, G; Cox, K; Estenfelder, S; Wang, J; Edelmann, J; Strefford, JC;... (2018-02)

Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigree

Tawana, K; Wang, J; Kiraly, PA; Kallay, K; Benyo, G; Zombori, M; Csomor, J; Al Seraihi, A; Rio-Machin, A; Matolcsy, A;... (2017-08)

Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma

Araf, S; Wang, J; Korfi, K; Pangault, C; Kotsiou, E; Rio-Machin, A; Rahim, T; Heward, J; Clear, A; Iqbal, S;... (2018-05)

PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer

Fearon, AE; Carter, EP; Clayton, NS; Wilkes, EH; Baker, A-M; Kapitonova, E; Bakhouche, BA; Tanner, Y; Wang, J; Gadaleta, E;... (Elsevier/Science Direct, 2018-02-27)

Development of resistance causes failure of drugs targeting receptor tyrosine kinase (RTK) networks and represents a critical challenge for precision medicine. Here, we show that PHLDA1 downregulation is critical to ...

'Multi-omic' data analysis using O-miner

Sangaralingam, A; Ullah, AZD; Marzec, J; Gadaleta, E; Nagano, A; Ross-Adams, H; Wang, J; Lemoine, NR; Chelala, C (2019-01)

1
2
3
4
. . .
5